Literature DB >> 29033509

Predictors of Impaired Reperfusion after Percutaneous Coronary Intervention in Patients with In-Hospital Acute Stent Thrombosis: A Retrospective Analyses of 5 Years of Data.

Burak Açar1, Orhan Maden1, Kevser Gülcihan Balci1, Sefa Ünal1, Mustafa Mücahit Balci1, Esra İpek Gücük1, Meryem Kara1, Hatice Selcuk1, Mehmet Timur Selcuk1.   

Abstract

BACKGROUND: Acute stent thrombosis (STh) is a rare complication of percutaneous coronary intervention (PCI) and is associated with a high-risk of reperfusion failure. However, data focusing on risk factors of reperfusion failure in patients undergoing repeat PCI for treatment of STh remains inadequate.
METHODS: A total of 8815 patients who underwent PCI with stent implantation from January 2009 to December 2013 were retrospectively reviewed. Among those cases, patients that presented with acute STh and underwent a repeat PCI for acute STh were identified.
RESULTS: There were 108 patients who underwent repeat PCI for the treatment of in-hospital acute STh that were retrospectively analyzed. Of these study subjects, 21 (25%) had thrombolysis in myocardial infarction (TIMI) flow < 3 after repeat PCI. The median value of pain-to-balloon time was 40 minutes in the TIMI < 3 group, 35 minutes in the TIMI = 3 group (p < 0.001), and the first PCI-to-stent thrombosis time was also longer in the TIMI < 3 group (10 hours vs. 2.5 hours, p = 0.001). When patients were evaluated according to PCI time, the percentage of patients with TIMI < 3 was significantly higher in the night period compared to the daytime period (46.4% vs. 17.5 %, p = 0.002). In the multivariable logistic regression analysis, stent length [odds ratio (OR) = 1.18, 95% confidence interval (CI) 1.008-1.38] and pain-to- balloon time (OR = 1.28, 95% CI, 1.06-1.54) were the only independent predictors of failed reperfusion.
CONCLUSIONS: Baseline stent length and pain-to-balloon time were associated with reperfusion failure in PCI for STh. Moreover, TIMI flow grade showed a circadian variation.

Entities:  

Keywords:  Coronary angiography; Primary percutaneous coronary intervention; Thrombolysis in myocardial infarction

Year:  2017        PMID: 29033509      PMCID: PMC5534418          DOI: 10.6515/acs20161026b

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN: 1011-6842            Impact factor:   2.672


  27 in total

Review 1.  No-reflow phenomenon.

Authors:  Shereif H Rezkalla; Robert A Kloner
Journal:  Circulation       Date:  2002-02-05       Impact factor: 29.690

2.  Paraoxonase-1 activity and oxidative stress in patients with anterior ST elevation myocardial infarction undergoing primary percutaneous coronary intervention with and without no-reflow.

Authors:  Mustafa Gür; Caner Türkoğlu; Abdullah Taşkın; Hakan Uçar; Abdurrezzak Börekçi; Taner Seker; Mehmet Yavuz Gözükara; Onur Kaypaklı; Selahattin Akyol; Sahbettin Selek; Durmuş Yıldıray Sahin; Zafer Elbasan; Murat Caylı
Journal:  Atherosclerosis       Date:  2014-04-03       Impact factor: 5.162

3.  Thinking about stent thrombosis: how does angiographic flow relate to outcome?

Authors:  Morton J Kern
Journal:  Catheter Cardiovasc Interv       Date:  2015-01-01       Impact factor: 2.692

4.  Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction.

Authors:  Gregg W Stone; Michael A Peterson; Alexandra J Lansky; George Dangas; Roxana Mehran; Martin B Leon
Journal:  J Am Coll Cardiol       Date:  2002-02-20       Impact factor: 24.094

5.  Cumulative sleepiness, mood disturbance, and psychomotor vigilance performance decrements during a week of sleep restricted to 4-5 hours per night.

Authors:  D F Dinges; F Pack; K Williams; K A Gillen; J W Powell; G E Ott; C Aptowicz; A I Pack
Journal:  Sleep       Date:  1997-04       Impact factor: 5.849

6.  Progressive decreases in coronary vein flow during reperfusion in acute myocardial infarction: clinical documentation of the no reflow phenomenon after successful thrombolysis.

Authors:  K Komamura; M Kitakaze; K Nishida; M Naka; J Tamai; M Uematsu; Y Koretsune; S Nanto; M Hori; M Inoue
Journal:  J Am Coll Cardiol       Date:  1994-08       Impact factor: 24.094

7.  Predictors of slow flow during primary percutaneous coronary intervention: an intravascular ultrasound-virtual histology study.

Authors:  J H Bae; T-G Kwon; D-W Hyun; C S Rihal; A Lerman
Journal:  Heart       Date:  2008-04-01       Impact factor: 5.994

8.  Tissue factor in patients with acute coronary syndromes: expression in platelets, leukocytes, and platelet-leukocyte aggregates.

Authors:  Marta Brambilla; Marina Camera; Deborah Colnago; Giancarlo Marenzi; Monica De Metrio; Peter L Giesen; Alessandra Balduini; Fabrizio Veglia; Karl Gertow; Paolo Biglioli; Elena Tremoli
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-02-21       Impact factor: 8.311

9.  Outcome of primary angioplasty for acute myocardial infarction during routine duty hours versus during off-hours.

Authors:  Jose P S Henriques; Arnout P Haasdijk; Felix Zijlstra
Journal:  J Am Coll Cardiol       Date:  2003-06-18       Impact factor: 24.094

10.  The impact of no-reflow phenomena after primary percutaneous coronary intervention: a time-dependent analysis of mortality.

Authors:  Eun Ho Choo; Pum Joon Kim; Kiyuk Chang; Youngkeun Ahn; Doo Soo Jeon; Jong Min Lee; Dong Bin Kim; Sung-Ho Her; Chul Soo Park; Hee Yeol Kim; Ki-Dong Yoo; Myung Ho Jeong; Ki-Bae Seung
Journal:  Coron Artery Dis       Date:  2014-08       Impact factor: 1.439

View more
  2 in total

1.  YiqiHuoxue Decoction and Its Ethanol Precipitation Show Anti-Platelet and Antithrombotic Effects by Suppressing Thromboxane B2 Formation.

Authors:  Hong Wu; Zhen Lei; Shuibo Gao; Liping Dai; Yongjun Han; Haixia Gao; Xinzhou Wang; Zhentao Wang; Lihua Han
Journal:  Acta Cardiol Sin       Date:  2019-09       Impact factor: 2.672

2.  A New Score for Determining Thrombus Burden in STEMI Patients: The MAPH Score.

Authors:  Ozge Ozcan Abacioglu; Arafat Yildirim; Mine Karadeniz; Serkan Abacioglu; Nermin Yildiz Koyunsever; Ferhat Dindas; Mustafa Dogdus; Mustafa Kaplangoray
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 3.512

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.